XML 199 R182.htm IDEA: XBRL DOCUMENT v3.25.0.1
Unaudited Quarterly Financial Information - Summary of Quarterly Results of Operations (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2024
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2024
Jun. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Quarterly Financial Information Disclosure [Abstract]                              
Net sales $ 1,359 $ 1,508 $ 1,554 $ 1,362 $ 1,368 $ 1,501 $ 1,660 $ 1,549 $ 2,915 $ 3,209 $ 4,423 $ 4,710 $ 5,782 $ 6,078 $ 6,831
Cost of goods sold 1,086 1,221 1,248 1,076 1,113 1,228 1,250 1,181 2,323 $ 2,431 $ 3,545 $ 3,659 4,631 4,772 5,215
Income (loss) before income taxes 9 (30) 82 67 (71) 13 (433) 173 $ 149       127 (318) 741
Net income (loss) (8) (27) 70 52 (18) 12 (376) 145         86 (237) 578
Net income (loss) attributable to Chemours $ (8) $ (27) $ 70 $ 52 $ (18) $ 12 $ (376) $ 145         $ 86 $ (238) $ 578
Basic earnings (loss) per share of common stock $ (0.05) $ (0.18) $ 0.47 $ 0.35 $ (0.12) $ 0.08 $ (2.52) $ 0.97         $ 0.58 $ (1.60) $ 3.72
Diluted earnings (loss) per share of common stock $ (0.05) $ (0.18) $ 0.46 $ 0.34 $ (0.12) $ 0.08 $ (2.52) $ 0.96         $ 0.57 $ (1.60) $ 3.65